Equities

Cipla Ltd

Cipla Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2005200520042003
ASSETS
Cash And Short Term Investments15462131
Total Receivables, Net7,5926,1214,757
Total Inventory7,4575,6895,892
Prepaid expenses2,1252,2171,948
Other current assets, total202272183
Total current assets17,52914,36212,911
Property, plant & equipment, net8,4496,0363,999
Goodwill, net------
Intangibles, net------
Long term investments1831,8041,266
Note receivable - long term------
Other long term assets------
Total assets26,16122,20218,177
LIABILITIES
Accounts payable2,3871,7772,042
Accrued expenses14711577
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total5,2504,9043,847
Total current liabilities7,7846,7965,966
Total long term debt1,9502,106948
Total debt1,9502,106948
Deferred income tax------
Minority interest------
Other liabilities, total889659562
Total liabilities10,6249,5617,476
SHAREHOLDERS EQUITY
Common stock600600600
Additional paid-in capital487487487
Retained earnings (accumulated deficit)14,34911,4529,511
Treasury stock - common------
Unrealized gain (loss)101102103
Other equity, total------
Total equity15,53612,64110,701
Total liabilities & shareholders' equity26,16122,20218,177
Total common shares outstanding300300300
Treasury shares - common primary issue------
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.